Skip to main content
. 2014 Jul 11;4(7):e005429. doi: 10.1136/bmjopen-2014-005429

TableĀ 5.

Key drug treatments of non-vascular conditions in vascular comorbidity

Numbers (%) Key drug treatments*
Unadjusted OR (95% CI) Adjusted OR (95% CI)
No Yes
COPD without vascular comorbidity 123 (22) 937 (88) 1.0 1.0
COPD and vascular comorbidity 87 (19) 382 (81) 0.58 (0.43 to 0.78) 0.55 (0.40 to 0.75)
OA without vascular comorbidity 281 (16) 1440 (84) 1.0 1.0
OA and vascular comorbidity 117 (17) 568 (83) 0.95 (0.75 to 1.20) 0.82 (0.64 to 1.06)
Depression without vascular comorbidity 259 (16) 1378 (84) 1.0 1.0
Depression and vascular group 120 (28) 311 (72) 0.49 (0.38 to 0.62) 0.55 (0.42 to 0.73)

*Drug treatment for COPD, OA or depression, respectively, adjusted for age, gender and deprivation as measured by Index of Multiple Deprivation.

COPD, chronic obstructive pulmonary disease; OA, osteoarthritis.